Literature DB >> 15570154

Reduction of serotonin transporters of patients with chronic fatigue syndrome.

Shigeyuki Yamamoto1, Yasuomi Ouchi, Hirotaka Onoe, Etsuji Yoshikawa, Hideo Tsukada, Hidetoshi Takahashi, Masao Iwase, Kouzi Yamaguti, Hirohiko Kuratsune, Yasuyoshi Watanabe.   

Abstract

To assess the involvement of serotonin in the symptoms of chronic fatigue syndrome, we investigated the serotonergic neurotransmitter system of chronic fatigue syndrome patients by the positron emission tomography (PET). Here we show that the density of serotonin transporters (5-HTTs) in the brain, as determined by using a radiotracer, [C](+)McN5652, was significantly reduced in the rostral subdivision of the anterior cingulate as compared with that in normal volunteers. This subdivision is different from that in the dorsal anterior cingulate in which binding potential values of individual patient showed a weak negative correlation with self-reported pain score of the patients. Therefore, an alteration of serotonergic system in the rostral anterior cingulate plays a key role in pathophysiology of chronic fatigue syndrome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15570154     DOI: 10.1097/00001756-200412030-00002

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  43 in total

Review 1.  A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome.

Authors:  Gerwyn Morris; Michael Maes
Journal:  Metab Brain Dis       Date:  2012-06-21       Impact factor: 3.584

Review 2.  Chronic fatigue syndrome: the need for subtypes.

Authors:  Leonard A Jason; Karina Corradi; Susan Torres-Harding; Renee R Taylor; Caroline King
Journal:  Neuropsychol Rev       Date:  2005-03       Impact factor: 7.444

3.  5-HT3 receptor antagonists ameliorate fatigue: so much potential, so little knowledge!

Authors:  N M Barnes
Journal:  Gut       Date:  2005-08       Impact factor: 23.059

4.  Altered serotonin transporter availability in patients with multiple sclerosis.

Authors:  Swen Hesse; Franziska Moeller; David Petroff; Donald Lobsien; Julia Luthardt; Ralf Regenthal; Georg-Alexander Becker; Marianne Patt; Eva Thomae; Anita Seese; Philipp M Meyer; Florian Then Bergh; Osama Sabri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-22       Impact factor: 9.236

5.  Cortical hypoactivation during resting EEG suggests central nervous system pathology in patients with chronic fatigue syndrome.

Authors:  M A Zinn; M L Zinn; I Valencia; L A Jason; J G Montoya
Journal:  Biol Psychol       Date:  2018-05-23       Impact factor: 3.251

6.  Is Autoimmune Thrombocytopenia Itself the Primary Disease in the Presence of Second Diseases Data from a Long-Term Observation.

Authors:  Nasra Aboud; Fabian Depré; Abdulgabar Salama
Journal:  Transfus Med Hemother       Date:  2016-10-18       Impact factor: 3.747

7.  Activity in the hypothalamo-hypophyseal-adrenocortical system on experimental induction of chronic fatigue syndrome.

Authors:  E E Fomicheva; T A Filatenkova; E G Rybakina
Journal:  Neurosci Behav Physiol       Date:  2010-02-10

8.  Fatigue in Parkinson's disease: The contribution of cerebral metabolic changes.

Authors:  Sang Soo Cho; Kelly Aminian; Crystal Li; Anthony E Lang; Sylvain Houle; Antonio P Strafella
Journal:  Hum Brain Mapp       Date:  2016-08-29       Impact factor: 5.038

9.  A systematic review of chronic fatigue syndrome: don't assume it's depression.

Authors:  James P Griffith; Fahd A Zarrouf
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

10.  Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment.

Authors:  S J Bull; P Huezo-Diaz; E B Binder; J F Cubells; G Ranjith; C Maddock; C Miyazaki; N Alexander; M Hotopf; A J Cleare; S Norris; E Cassidy; K J Aitchison; A H Miller; C M Pariante
Journal:  Mol Psychiatry       Date:  2008-05-06       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.